Back
Rigel Pharmaceuticals Stock Price Chart

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Sell
44
RIGL
Rigel Pharmaceuticals
Last Price:
$18.37
Seasonality Move:
-1.01%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
Rigel Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.78 | Sell |
20-day SMA: | 18.37 | Buy |
50-day SMA: | 18.82 | Sell |
200-day SMA: | 17.8 | Buy |
8-day EMA: | 18.74 | Sell |
20-day EMA: | 18.57 | Buy |
50-day EMA: | 18.83 | Sell |
200-day EMA: | 17.75 | Buy |
Rigel Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 50.26 | Buy |
Chaikin Money Flow: | -159868 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.94 - 19.14) | Buy |
Bollinger Bands (100): | (17.25 - 21.31) | Sell |
Rigel Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Rigel Pharmaceuticals Stock
Is Rigel Pharmaceuticals Stock a Buy?
-
Rigel Pharmaceuticals share price is 18.61 while RIGL 8-day simple moving average is 18.78, which is a Sell signal.
-
The stock price of RIGL is 18.61 while Rigel Pharmaceuticals 20-day SMA is 18.37, which makes it a Buy.
-
Rigel Pharmaceuticals 50-day simple moving average is 18.82 while RIGL share price is 18.61, making it a Sell technically.
-
RIGL stock price is 18.61 and Rigel Pharmaceuticals 200-day simple moving average is 17.80, creating a Buy signal.
RIGL Technical Analysis vs Fundamental Analysis
Sell
44
Rigel Pharmaceuticals (RIGL)
is a Sell
Is Rigel Pharmaceuticals a Buy or a Sell?
-
Rigel Pharmaceuticals stock is rated a SellThe current Rigel Pharmaceuticals [RIGL] share price is $18.61. The Score for RIGL is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Rigel Pharmaceuticals Stock Info
Market Cap:
332.6M
Price in USD:
18.61
Share Volume:
218K
Rigel Pharmaceuticals 52-Week Range
52-Week High:
29.82
52-Week Low:
7.48
Sell
44
Rigel Pharmaceuticals (RIGL)
is a Sell
Rigel Pharmaceuticals Share Price Forecast
-
What is the Rigel Pharmaceuticals stock price today?The Rigel Pharmaceuticals stock price is 18.61 USD today.
-
Will RIGL stock go up or go down?Rigel Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rigel Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rigel Pharmaceuticals is overvalued.
Is Rigel Pharmaceuticals Stock a Buy?
-
Rigel Pharmaceuticals share price is 18.61 while RIGL 8-day exponential moving average is 18.74, which is a Sell signal.
-
The stock price of RIGL is 18.61 while Rigel Pharmaceuticals 20-day EMA is 18.57, which makes it a Buy.
-
Rigel Pharmaceuticals 50-day exponential moving average is 18.83 while RIGL share price is 18.61, making it a Sell technically.
-
RIGL stock price is 18.61 and Rigel Pharmaceuticals 200-day simple moving average is 17.75, creating a Buy signal.
Fundamental Analysis of Rigel Pharmaceuticals
Is Rigel Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.21 per share, an increase this year of $1.86 per share, and a decrease next year of $0.27 per share.
Technical Analysis of Rigel Pharmaceuticals
Should I short Rigel Pharmaceuticals stock?
-
RIGL Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Rigel Pharmaceuticals is a Buy
-
Rigel Pharmaceuticals Relative Strength Index (RSI) is 50.26, which suggest Rigel Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Rigel Pharmaceuticals is (16.94 - 19.14), which suggest Rigel Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Rigel Pharmaceuticals is (17.25 - 21.31), which suggest Rigel Pharmaceuticals is a Sell
* Rigel Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.